International Journal of Engineering and Manufacturing (IJEM)
IJEM Vol. 16, No. 4, 8 Aug. 2026
Cover page and Table of Contents: PDF (size: 1677KB)
An Interpretable Machine Learning Framework for Breast Cancer Diagnosis Using Statistical Feature Analysis and Ensemble Classification
PDF (1677KB), PP.228-252
Views: 0 Downloads: 0
Author(s)
T. Haripriya
1
M.V. Ramana Murthy
2
Ch. Vasavi
1
Swathi Gowroju
3
G. Srinivas
4
Devineni Gireesh Kumar
3,*
Index Terms
Interdisciplinary modelling, Cancer classification, Machine learning, Ensemble methods, Feature importance, Precision oncology
Abstract
A clear, statistically sound, yet easily understandable breast cancer diagnosis is a difficult issue in all healthcare systems, because early stages of breast cancer are critical in therapy success and long-term survivability. This machine-learning-based breast cancer classifier, in a statistically justified, rigorously experimentally validated way, classifies a set of 569 breast cancer cases with 9 cytological features for breast cancer diagnosis. The classifier uses a rigorous set of data cleanup measures, including missing-value substitution, correlation-based feature reduction, and projection into principal component space, to achieve high data quality, reduce redundancy, and enhance feature usefulness. Five supervised classifiers, in a widely accepted train-test model using an 80:20 random sample split and 5-fold cross-validation, are fitted and evaluated using Accuracy, Precision, Recall, F1-score, and Area under the ROC curve. In these tests, the Random Forest classifier got the best result, with 95.84% Accuracy, 95.31% Precision, 95.12% Recall, 95.21% F1-score and 0.982 area under the ROC curve; in a statistically sound consistency test using cross-validation, its mean accuracy reached 95.96% with a small standard deviation of 0.43. To provide a clear, interpretable indication of which features truly matter, we performed a feature-importance analysis on the best classifier, the Random Forest model. Results show that the expression levels of Bland Chromatin, Single Epithelial Cell Size, Normal Nucleoli, Uniformity of Cell Shape, Uniformity of Cell Size and Bare Nuclei are closely related to breast cancer diagnosis; this is almost the same as the clinical diagnosis findings, and very naturally suggests that abnormalities of cellular morphology and nuclei are major symptoms of breast cancer. In comparison, prior research may neglect validation and efficiency comparisons or focus only on the classifier's accuracy. Our method combines multiple levels of assessment (statistical data-by-data validation, feature importance, cross-validation, and comparison of different classifiers using ensemble learning) into a single evaluation system. This combined approach not only enhances predictive capability but also makes the entire setup more explicitly interpretable from a clinical perspective, thereby making it more suitable for health care decision support. Given the strong classification performance, interpretability, and validation suggested above, the model would help physicians detect breast cancer very early, reducing the risk of misdiagnosis.
Cite This Paper
T. Haripriya, M.V. Ramana Murthy, Ch. Vasavi, Swathi Gowroju, G. Srinivas, Devineni Gireesh Kumar, "An Interpretable Machine Learning Framework for Breast Cancer Diagnosis Using Statistical Feature Analysis and Ensemble Classification", International Journal of Engineering and Manufacturing (IJEM), Vol.16, No.4, pp.228-252, 2026. DOI:10.5815/ijem.2026.04.16
Reference
[1]N. Mustafee, A. Harper, and B. S. Onggo, "Hybrid Modelling and Simulation (M&S): Driving Innovation in the Theory and Practice of M&S," in 2020 Winter Simulation Conference (WSC), Orlando, FL, USA, 2020, pp. 3140-3151, doi: https://doi.org/10.1109/WSC48552.2020.9383892.
[2]A. S. Panayides et al., "AI in Medical Imaging Informatics: Current Challenges and Future Directions," in IEEE Journal of Biomedical and Health Informatics, vol. 24, no. 7, pp. 1837-1857, July 2020, doi: https://doi.org/10.1109/JBHI.2020.2991043.
[3]M. T. Nyo, F. Mebarek-Oudina, S. S. Hlaing et al., "Otsu’s thresholding technique for MRI image brain tumor segmentation," in Multimedia Tools and Applications, vol. 81, pp. 43837–43849, 2022, doi: https://doi.org/10.1007/s11042-022-13215-1.
[4]N. Noreen, S. Palaniappan, A. Qayyum, I. Ahmad, M. Imran, and M. Shoaib, "A Deep Learning Model Based on Concatenation Approach for the Diagnosis of Brain Tumor," in IEEE Access, vol. 8, pp. 55135-55144, 2020, doi: https://doi.org/10.1109/ACCESS.2020.2978629.
[5]M. H. Khammash and J. Stelling, "Systems and Synthetic Biology [Scanning the Issue]," in Proceedings of the IEEE, vol. 110, no. 5, pp. 518-522, May 2022, doi: https://doi.org/10.1109/JPROC.2022.3173798.
[6]D. Bi, A. Almpanis, A. Noel, Y. Deng, and R. Schober, "A Survey of Molecular Communication in Cell Biology: Establishing a New Hierarchy for Interdisciplinary Applications," in IEEE Communications Surveys & Tutorials, vol. 23, no. 3, pp. 1494-1545, 3rd Quart., 2021, doi: https://doi.org/10.1109/COMST.2021.3066117.
[7]R. J. Chen, M. Y. Lu, J. Wang, D. F. K. Williamson, S. J. Rodig, N. I. Lindeman, and F. Mahmood, "Pathomic Fusion: An Integrated Framework for Fusing Histopathology and Genomic Features for Cancer Diagnosis and Prognosis," in IEEE Transactions on Medical Imaging, vol. 41, no. 4, pp. 757-770, Apr. 2022, doi: https://doi.org/10.1109/TMI.2020.3021387.
[8]Z. Fei, Y. Ryeznik, O. Sverdlov, C. W. Tan, and W. K. Wong, "An Overview of Healthcare Data Analytics with Applications to the COVID-19 Pandemic," in IEEE Transactions on Big Data, vol. 8, no. 5, pp. 1163-1178, Oct. 2022, doi: https://doi.org/10.1109/TBDATA.2021.3103458.
[9]Y. Censor, K. E. Schubert, and R. W. Schulte, "Developments in Mathematical Algorithms and Computational Tools for Proton CT and Particle Therapy Treatment Planning," in IEEE Transactions on Radiation and Plasma Medical Sciences, vol. 6, no. 3, pp. 313-324, Mar. 2022, doi: https://doi.org/10.48550/arXiv.2108.09459.
[10] C. Venkatesan, D. Balamurugan, T. Thamaraimanalan, and M. Ramkumar, "Efficient Machine Learning Technique for Tumor Classification Based on Gene Expression Data," in Proceedings of the 2022 8th International Conference on Advanced Computing and Communication Systems (ICACCS), Coimbatore, India, 2022, pp. 1982-1986, doi: https://doi.org/10.1109/ICACCS54159.2022.9785294.
[11]L. Chazette, W. Brunotte, and T. Speith, "Exploring Explainability: A Definition, a Model, and a Knowledge Catalogue," in Proceedings of the 2021 IEEE 29th International Requirements Engineering Conference (RE), Notre Dame, IN, USA, 2021, pp. 197-208, doi: https://doi.org/10.1109/RE51729.2021.00025.
[12]A. Qayyum, J. Qadir, M. Bilal, and A. Al-Fuqaha, "Secure and Robust Machine Learning for Healthcare: A Survey," in IEEE Reviews in Biomedical Engineering, vol. 14, pp. 156-180, 2021, doi: https://doi.org/10.1109/RBME.2020.3013489.
[13]S. Bharati, M. R. H. Mondal, and P. Podder, "A Review on Explainable Artificial Intelligence for Healthcare: Why, How, and When?," in IEEE Transactions on Artificial Intelligence, vol. 5, no. 4, pp. 1429-1442, Apr. 2024, doi: https://doi.org/10.1109/TAI.2023.3266418.
[14]M. F. Ak, "A Comparative Analysis of Breast Cancer Detection and Diagnosis Using Data Visualization and Machine Learning Applications," in Healthcare, vol. 8, no. 2, p. 111, 2020, doi: https://doi.org/10.3390/healthcare8020111.
[15]M. Cekikj, M. J. Özdemir, S. Kalajdzhiski, O. Özcan, and O. U. Sezerman, "Understanding the Role of the Microbiome in Cancer Diagnostics and Therapeutics by Creating and Utilizing ML Models," in Applied Sciences, vol. 12, no. 9, p. 4094, 2022, doi: https://doi.org/10.3390/app12094094.
[16] Garberis, V. Gaury, C. Saillard et al., "Deep learning assessment of metastatic relapse risk from digitized breast cancer histological slides," in Nature Communications, vol. 16, p. 5876, 2025, doi: https://doi.org/10.1038/s41467-025-60824-z.
[17]N. A. Ghafoor and A. Yildiz, "Targeting MDM2–p53 Axis through Drug Repurposing for Cancer Therapy: A Multidisciplinary Approach," in ACS Omega, vol. 8, no. 38, pp. 34583-34596, Sep. 2023, doi: https://doi.org/10.1021/acsomega.3c03471.
[18]X. Guan, Y. Du, R. Ma et al., "Construction of the XGBoost model for early lung cancer prediction based on metabolic indices," in BMC Medical Informatics and Decision Making, vol. 23, p. 107, 2023, doi: https://doi.org/10.1186/s12911-023-02171-x.
[19]A. J. Preto, P. Matos-Filipe, J. Mourão, and I. S. Moreira, "SYNPRED: prediction of drug combination effects in cancer using different synergy metrics and ensemble learning," in GigaScience, vol. 11, p. giac087, 2022, doi: https://doi.org/10.1093/gigascience/giac087.
[20]J. Vrdoljak, Z. Boban, D. Barić, D. Šegvić, M. Kumrić, M. Avirović, M. Perić Balja, M. M. Periša, Č. Tomasović, S. Tomić, E. Vrdoljak, and J. Božić, "Applying Explainable Machine Learning Models for Detection of Breast Cancer Lymph Node Metastasis in Patients Eligible for Neoadjuvant Treatment," in Cancers, vol. 15, no. 3, p. 634, Jan. 2023, doi: https://doi.org/10.3390/cancers15030634.
[21]A. Prayongrat, N. Srimaneekarn, K. Thonglert et al., "Machine learning-based normal tissue complication probability model for predicting albumin-bilirubin (ALBI) grade increase in hepatocellular carcinoma patients," in Radiation Oncology, vol. 17, p. 202, 2022, doi: https://doi.org/10.1186/s13014-022-02138-8.
[22]A. Janssen, F. C. Bennis, and R. A. A. Mathôt, "Adoption of Machine Learning in Pharmacometrics: An Overview of Recent Implementations and Their Considerations," in Pharmaceutics, vol. 14, no. 9, p. 1814, 2022, doi: https://doi.org/10.3390/pharmaceutics14091814.